Cara Therapeutics Inc (CARA)

Finanzdaten der Cara Therapeutics Inc-Aktie (CARA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	28.93% 2.135	3.004	4.866	6.933	6.165
Operating Expenses	10.70% 31.80	35.61	33.76	39.27	33.81
Benefits Costs and Expenses	7.10% 32.83	35.34	-	-	32.83
Costs And Expenses	7.10% 32.83	35.34	33.76	39.27	32.83
Operating Income/Loss	9.02% -29.67	-32.61	-28.90	-32.34	-27.65
Income/Loss From Continuing Operations Before Tax	5.07% -30.70	-32.34	4.866	-31.48	-26.66
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	5.07% -30.70	-32.34	-28.03	-31.48	-26.66
Net Income/Loss	5.07% -30.70	-32.34	-28.03	-31.48	-26.66
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	49,158% 54.59	0.1108	54.24	54.00	53.87
Diluted Average Shares	49,158% 54.59	0.1108	54.24	54.00	53.87
Basic Earnings Per Share	6.67% -0.56	-0.60	-0.52	-0.58	-0.49
Diluted Earnings Per Share	6.67% -0.56	-0.60	-0.52	-0.58	-0.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-